^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

SDC1 positive

i
Other names: SDC1, Syndecan 1, Syndecan Proteoglycan 1, CD138 Antigen, Syndecan-1, SYND1, SDC, Heparan Sulfate Proteoglycan Fibroblast Growth Factor Receptor, Syndecan, CD138
Entrez ID:
Related biomarkers:
11ms
A rare case of concurrent JAK2V617F-positive essential thrombocythemia, multiple myeloma, and colorectal adenocarcinoma. (PubMed, Indian J Pathol Microbiol)
Additionally, the patient responded well to a bortezomib-based treatment regimen, despite the absence of specific therapy for ET. We believe that our findings add new understanding to these rare diseases and encourage further research in this area.
Journal
|
SDC1 (Syndecan 1)
|
JAK2 V617F • SDC1 positive
|
bortezomib
11ms
Syndecan-1 and E-Cadherin Expression in Canine Cutaneous Squamous Cell Carcinoma. (PubMed, Vet Sci)
E-cadherin reduction and stromal syndecan-1 positivity seem to be associated with tumor aggressiveness in canine cutaneous squamous cell carcinoma. Further studies are needed to explore their roles in tumor progression.
Journal
|
CDH1 (Cadherin 1) • SDC1 (Syndecan 1)
|
CDH1 expression • SDC1 positive
1year
Isolated plasmacytoma of the breast: A rare case report. (PubMed, Int J Surg Case Rep)
Continuous follow-up is essential to monitor for potential recurrence or progression. This case contributes to the limited literature on this rare entity and highlights the need for further research to develop standardized management protocols.
Journal
|
SDC1 (Syndecan 1)
|
SDC1 positive
1year
Plasmablastic Lymphoma in the Submandibular Region Diagnosed by FNAC: A Case Report and Literature Review. (PubMed, Cytopathology)
This study highlights the efficacy of FNAC in diagnosing PBL. The immunophenotypic profile and morphological features observed through FNAC, combined with immunohistochemistry (IHC) and in situ hybridisation, were crucial for an accurate diagnosis. The literature review underscores the value of FNAC as a diagnostic tool for PBL, demonstrating a high rate of cytological diagnosis and significant cytohistological concordance.
Review • Journal
|
ALK (Anaplastic lymphoma kinase) • CD20 (Membrane Spanning 4-Domains A1) • PAX5 (Paired Box 5) • SDC1 (Syndecan 1) • CD79A (CD79a Molecule) • IRF4 (Interferon regulatory factor 4)
|
SDC1 positive
1year
An unusual pattern of endometrial involvement: superficial spreading squamous cell carcinoma of the cervix. (PubMed, Front Oncol)
Superficial spread of cervical cancer towards the endometrium is a rare but cognizable phenomenon, and a guideline for the management of these cases has not been established. Our present findings suggest that multiple factors may interact with each other simultaneously, contributing to this rare disease.
Journal
|
CD34 (CD34 molecule) • SDC1 (Syndecan 1) • TP63 (Tumor protein 63)
|
SDC1 positive
1year
An Uncommon Finding of Plasma Cell Invasion of the Kidney in a Patient with Plasma Cell Dyscrasia: Should It be Considered a Myeloma Defining Event? (PubMed, J Assoc Physicians India)
In the present situation of clinically unexplained renal failure with suspicion of plasma cell dyscrasia, a kidney biopsy proved to be key to the diagnosis. Hence, malignant plasma cell infiltration in the kidney could indicate underlying plasma cell dyscrasia and may serve as a future myeloma defining event (MDE).
Journal
|
SDC1 (Syndecan 1)
|
SDC1 positive
1year
Gaucher-like crystal-storing histiocytosis associated with kappa chain myeloma: A case report with next generation sequencing study. (PubMed, Pathol Res Pract)
Accordingly, this case died of pneumonia with septic shock during treatment. Our findings suggest that the presence of rhomboid crystals in bone marrow smears may alert pathologists to look for the possibility of crystal-storing histiocytosis and the prognosis of patients with multiple myeloma may depend on the genetic features of tumor cells rather than the association with crystal-storing histiocytosis.
Journal • PARP Biomarker • Next-generation sequencing
|
STK11 (Serine/threonine kinase 11) • KDR (Kinase insert domain receptor) • MSH6 (MutS homolog 6) • PARP1 (Poly(ADP-Ribose) Polymerase 1) • SDC1 (Syndecan 1) • CCND3 (Cyclin D3)
|
STK11 mutation • CD38 positive • SDC1 positive
|
TruSight Oncology 500 Assay
1year
Breast Cancer With Release of Tumor Cells in Peripheral Blood Mimicking Acute Myeloid Leukemia. (PubMed, J Hematol)
The FC analysis of the peripheral blood allowed the rapid characterization of a non-hematological neoplastic cell population, circulating at unusually high frequency and mimicking an acute myeloid leukemia. The FC detection of CD45-negative cell populations in peripheral blood, bone marrow or lymph node aspirate should prompt the setup of an immunophenotyping panel including EpCAM, CD9, CD56 and CD117, to allow for a rapid and accurate identification of ectopic malignant epithelial cells.
Journal • IO biomarker • Tumor cell
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • CD38 (CD38 Molecule) • CD34 (CD34 molecule) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • NCAM1 (Neural cell adhesion molecule 1) • EPCAM (Epithelial cell adhesion molecule) • SDC1 (Syndecan 1) • CD9 (CD9 Molecule) • TFRC
|
CD38 positive • NCAM1 expression • CD9 expression • SDC1 positive • EPCAM expression
over1year
Case Report: A very rare case of a Pleural Effusion revealing Multiple Myeloma. (PubMed, F1000Res)
Unfortunately, our patient died one month after the initial diagnosis. We present also a review of the recent literature in order to highlight the clinical presentations of the myelomatous pleural effusion, the diagnostic tools, the therapeutic strategies as well as the outcomes.
Journal • Pleural effusion
|
SDC1 (Syndecan 1) • IRF4 (Interferon regulatory factor 4)
|
SDC1 positive
over1year
Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer. (PubMed, Cancers (Basel))
Overall, 73.1% (49/67) of cervical cancer samples are CD138-positive with 38.8% (26/67) of cervical cancer samples showing at least moderate or high expression. (4) TROP2, CEACAM5 or CD138 do seem suitable for further clinical research and the data presented here might be used to guide further clinical trials with ADCs in advanced and recurrent cervical cancer patients.
Journal
|
FOLR1 ( Folate receptor alpha ) • MSLN (Mesothelin) • CEACAM5 (CEA Cell Adhesion Molecule 5) • DLL3 (Delta Like Canonical Notch Ligand 3) • CD70 (CD70 Molecule) • NCAM1 (Neural cell adhesion molecule 1) • SDC1 (Syndecan 1) • GPNMB (Glycoprotein Nmb) • TACSTD2 (Tumor Associated Calcium Signal Transducer 2)
|
TROP2 expression • CD70 expression • SDC1 positive
over1year
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression. (PubMed, J Hematop)
ALK + LBCL can present with an ambiguous immunophenotype, which warrants the use of multiple B cell, T cell, and plasmacytic antibodies. CD3 expression in this entity is rare and of uncertain clinical significance, but warrants further study.
Journal • IO biomarker
|
ALK (Anaplastic lymphoma kinase) • BCL2 (B-cell CLL/lymphoma 2) • CD20 (Membrane Spanning 4-Domains A1) • BCL6 (B-cell CLL/lymphoma 6) • CD22 (CD22 Molecule) • PAX5 (Paired Box 5) • PTPRC (Protein Tyrosine Phosphatase Receptor Type C) • ALK1 (Activin A Receptor Like Type 1) • SDC1 (Syndecan 1) • CD79A (CD79a Molecule) • IRF4 (Interferon regulatory factor 4)
|
ALK positive • PTPRC expression • SDC1 positive
almost2years
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study. (PubMed, Leuk Lymphoma)
An increased number of mutations detected in cfDNA were associated with a decreased overall survival. In conclusion, we demonstrated cfDNA NGS analysis feasibility and accuracy in R/R MM patients who may benefit from early phase clinical trial.
Journal
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • NRAS (Neuroblastoma RAS viral oncogene homolog) • SDC1 (Syndecan 1) • TENT5C (Terminal Nucleotidyltransferase 5C)
|
SDC1 positive